Home Contact Center Add this

23 March 2017 / international

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study [Read more]

09 March 2017 / International

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case [Read more]

07 March 2017 / International

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics [Read more]

ALL NEWS

09 March 2017

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case [Read more]

07 March 2017

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics [Read more]

09 January 2017

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe [Read more]

ALL NEWS

18 December 2014

Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities [Read more]

27 November 2014

Debiopharm Investment becomes a minority shareholder in Haut-Lac International Bilingual School in St-Légier (VD) [Read more]

ALL NEWS

01 December 2016

Chemosensitization to Carboplatin and Paclitaxel by IAP Inhibitor Debio 1143 in Ovarian Cancer Cell Lines: Signature Identification for Potential Patient Stratification [Read more]

29 October 2016

Paclitaxel-Carboplatin With The Oral Iap Inhibitor Debio1143 In A Subset Of Patients With Recurrent Epithelial Ovarian Cancer (EOC): Phase I [Read more]

29 October 2016

The Staphylococcal-specific Antibiotic Debio 1450 Minimizes Disturbance to the Gut Microbiota in Mice [Read more]

ALL NEWS

bulle slideshow group

bulle slideshow diagnostics

bulle slideshow international

bulle slideshow investment

bulle slideshow research